Cargando…

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome

BACKGROUND: Short‐chain fatty acids (SCFAs) may play a role in the pathophysiology of irritable bowel syndrome (IBS). This study analyzed fecal SCFAs after performing fecal microbiota transplantation (FMT) in the IBS patients who were included in our previous study of the efficacy of FMT. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales:	El‐Salhy, Magdy, Valeur, Jørgen, Hausken, Trygve, Gunnar Hatlebakk, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900992/ https://www.ncbi.nlm.nih.gov/pubmed/32945066 http://dx.doi.org/10.1111/nmo.13983

Ejemplares similares

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation
por: El‐Salhy, Magdy, et al.
Publicado: (2022)

Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2021)

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2018)

Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS)
por: El-Salhy, Magdy, et al.
Publicado: (2019)

Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones
por: El-Salhy, Magdy, et al.
Publicado: (2019)

Density of Musashi-1-positive stem cells in the stomach of patients with irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2020)

The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
por: Mazzawi, Tarek, et al.
Publicado: (2021)

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
por: El-Salhy, Magdy, et al.
Publicado: (2020)

Stomach antral endocrine cells in patients with irritable bowel syndrome
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21(st) century
por: El-Salhy, Magdy, et al.
Publicado: (2021)

The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2015)

Effects of a Cod Protein Hydrolysate Supplement on Symptoms, Gut Integrity Markers and Fecal Fermentation in Patients with Irritable Bowel Syndrome
por: Dale, Hanna Fjeldheim, et al.
Publicado: (2019)

Duodenal Chromogranin A Cell Density as a Biomarker for the Diagnosis of Irritable Bowel Syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2014)

The Effect of Anaerobically Cultivated Human Intestinal Microbiota Compared to Fecal Microbiota Transplantation on Gut Microbiota Profile and Symptoms of Irritable Bowel Syndrome, a Double-Blind Placebo-Controlled Study
por: Mazzawi, Tarek, et al.
Publicado: (2022)

Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (Review)
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report
por: El-Salhy, Magdy, et al.
Publicado: (2013)

Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease
por: El-Salhy, Magdy, et al.
Publicado: (2017)

Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2020)

2073: Fecal bile acids, fecal short-chain fatty acids and the intestinal microbiota in patients with irritable bowel syndrome (IBS) and control volunteers
por: Shin, Andrea, et al.
Publicado: (2018)

2103 Fecal bile acids, fecal short-chain fatty acids, and the intestinal microbiota in patients with irritable bowel syndrome (IBS) and control volunteers
por: Shin, Andrea, et al.
Publicado: (2018)

Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome
por: MAZZAWI, TAREK, et al.
Publicado: (2014)

Sex‐based differences in fecal short‐chain fatty acid and gut microbiota in irritable bowel syndrome patients
por: Sun, Qing Hua, et al.
Publicado: (2021)

Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting
por: El-Salhy, Magdy, et al.
Publicado: (2019)

Interaction between diet and gastrointestinal endocrine cells
por: EL-SALHY, MAGDY, et al.
Publicado: (2016)

Increased Chromogranin A Cell Density in the Large Intestine of Patients with Irritable Bowel Syndrome after Receiving Dietary Guidance
por: Mazzawi, Tarek, et al.
Publicado: (2015)

Can fecal microbiota transplantation cure irritable bowel syndrome?
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2017)

Associations of Fecal Short Chain Fatty Acids With Colonic Transit, Fecal Bile Acid, and Food Intake in Irritable Bowel Syndrome
por: Waseem, Mohammed Rayyan, et al.
Publicado: (2022)

The role of peptide YY in gastrointestinal diseases and disorders
por: EL-SALHY, MAGDY, et al.
Publicado: (2013)

Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome
por: Wang, Yao, et al.
Publicado: (2019)

Low Densities of Serotonin and Peptide YY Cells in the Colon of Patients with Irritable Bowel Syndrome
por: El-Salhy, M., et al.
Publicado: (2011)

Chromogranin A Cell Density as a Diagnostic Marker for Lymphocytic Colitis
por: El-Salhy, Magdy, et al.
Publicado: (2012)

Postprandial Symptoms in Patients With Functional Dyspepsia and Irritable Bowel Syndrome: Relations to Ultrasound Measurements and Psychological Factors
por: Steinsvik, Elisabeth K, et al.
Publicado: (2020)

Diet in irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2015)

Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome
por: Tang, Binbin, et al.
Publicado: (2023)

Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome: A systematic review and meta-analysis
por: Sun, Qinghua, et al.
Publicado: (2019)

Fecal microbiota transplantation for patients with irritable bowel syndrome: A meta-analysis protocol
por: Wen, Wenting, et al.
Publicado: (2018)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

Chromogranin A cell density in the rectum of patients with irritable bowel syndrome
por: EL-SALHY, M., et al.
Publicado: (2012)

Fecal microbiota transplantation against irritable bowel syndrome? Rigorous randomized clinical trials are required
por: Abadi, Amin Talebi Bezmin
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rumbj2qmo4nftf3dfkr2gpsdkm